Anna Weiss, MD
Surgical Oncology · Rochester, NYNPI 1114183456
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Merck accounts for 84.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $17,569 and has fallen 67.3% since, to $5,753 in 2025. Among surgical oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $745.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$23K
- Daiichi Sankyo Inc.$2K
- AbbVie$793
- Endomagnetics Ltd$605
- Hologic Sales And Service, LLC$375
- Dilon Technologies, Inc.$160
- plus $699 from 7 others
Across 1 payment — averaging $245.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$245
What the payments were for
- Consulting fees$14,49254%
- Travel & lodging$9,98137%
- Food & beverage$2,3569%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $22,687 |
| Daiichi Sankyo Inc. | 6 | $1,511 |
| AbbVie | 1 | $793 |
| Endomagnetics Ltd | 7 | $605 |
| Hologic Sales And Service, LLC | 2 | $375 |
| Dilon Technologies, Inc. | 1 | $160 |
| AstraZeneca | 2 | $157 |
| Elucent Medical | 1 | $137 |
| Stemline Therapeutics Inc. | 1 | $124 |
| Johnson & Johnson | 1 | $119 |
| KUB Technologies Inc. | 1 | $83 |
| Medtronic | 1 | $65 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$9,831
- Enhertu$1,475
- Magseed$627
- Magtrace$627
- SENTIMAG$375
- HemoBlast Bellows$160
- Orserdu$124
- STRATAFIX$119
- ECHELON ENDOPATH Stapler$119
- HARMONIC Product Family$119
- EVICEL Fibrin Sealant (Human)$119
- Megadyne Ace Blade 700$119
How this compares
$26,830 in reported general payments places this provider in the 95th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Rochester
- Daniel TuvinRochester$7K
- Luke SchoenigerRochester$4K
- Maitham MoslimRochester$4K
- Sheldon FeldmanNew York$97K
- Kepal PatelNew York$94K
- Helen CappuccinoBuffalo$70K
- Jose Alberty OllerStaten Island$63K
- Megan WinnerMineola$51K
- George PlitasNew York$39K
- James ParkNew York$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.